書籍情報から探す
Lessons Learned : Challenges in the Design of the First Pivotal Phase III Trials for a New Indication
Andrew J.Cole*
*MGH Epilepsy Service, Department of Neurology, Massachusetts General Hospital, Harvard Medical School
Neurological Therapeutics 37 (3) 236-236, 2020.
*MGH Epilepsy Service, Department of Neurology, Massachusetts General Hospital, Harvard Medical School
Neurological Therapeutics 37 (3) 236-236, 2020.
- アブストラクト: 従量制は110円(税込)、基本料金制は基本料金に含まれます。
LRRK 2 gene mutations in the pathophysiology of the ROCO domain and therapeutic targets for Parkinson's disease
Ruey-Meei Wu*
*Department of Neurology, National Taiwan University Hospital, College of Medicine, National Taiwan University
Neurological Therapeutics 37 (3) 237-237, 2020.
*Department of Neurology, National Taiwan University Hospital, College of Medicine, National Taiwan University
Neurological Therapeutics 37 (3) 237-237, 2020.
- アブストラクト: 従量制は110円(税込)、基本料金制は基本料金に含まれます。